ACR 2022 Guideline on Glucocorticoid-Induced Osteoporosis
The ACR has published its updated recommendations for prevention and treatment of GIOP for patients receiving >3 months treatment with glucocorticoids (GCs) ≥2.5 mg daily.
https://t.co/oKVovOafl7 https://t.co/irxsAxMwKA
Links:
ACR 2022 Guideline on Glucocorticoid-Induced Osteoporosis | RheumNow
https://bit.ly/3rW1TVH
26-10-2023


